Minoru Nagi
Impact in
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
-
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Autophagy in Disease and Therapy
Papers in
-
- Antifungal resistance and susceptibility 25
- Epidemiology 20
- Fungal Infections and Studies 15
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Nail Diseases and Treatments 4
- Co-authors
- Yoshitsugu Miyazaki (26 shared papers)Koichi Tanabe (16 shared papers)Keigo Ueno (9 shared papers)Takashi Umeyama (9 shared papers)Hironobu Nakayama (9 shared papers)Satoshi Yamagoe (9 shared papers)Hideaki Ohno (6 shared papers)Toshihiro Aoyama (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Medical Mycology (3 papers)Molecular Microbiology (2 papers)PLoS ONE (2 papers)Genes to Cells (2 papers)
- Partner nations
- JapanUnited StatesNew Zealand
In The Last Decade
Minoru Nagi
33 papers receiving 416 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 260
- Epidemiology 206
- Molecular Medicine 18
- Pharmacology 61
- Periodontics 13
Countries citing papers authored by Minoru Nagi
This map shows the geographic impact of Minoru Nagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Nagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Nagi more than expected).
Fields of papers citing papers by Minoru Nagi
This network shows the impact of papers produced by Minoru Nagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Nagi. The network helps show where Minoru Nagi may publish in the future.
Co-authors
The 25 scholars most cited alongside Minoru Nagi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 47 | |
| 2 | 2016 | 40 | |
| 3 | 2013 | 29 | |
| 4 | 2018 | 28 | |
| 5 | 2013 | 25 | |
| 6 | 2020 | 24 | |
| 7 | 2018 | 21 | |
| 8 | 2011 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2010 | 16 | |
| 11 | 2015 | 15 | |
| 12 | 2021 | 15 | |
| 13 | 2022 | 13 | |
| 14 | 2009 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2017 | 9 | |
| 17 | Serum or bile affects the in vitro azole susceptibilities of Candida spp. | 2009 | 9 |
| 18 | 2019 | 9 | |
| 19 | 2012 | 8 | |
| 20 | 2014 | 8 |
About Minoru Nagi
Minoru Nagi is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Pharmacology and Oncology, having authored 34 papers that have together received 419 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (25 papers), Fungal Infections and Studies (15 papers), Fungal and yeast genetics research (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Nail Diseases and Treatments (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Fungal Biology and Applications (3 papers). The work is most often cited by research in Infectious Diseases (260 citations), Epidemiology (206 citations), Molecular Medicine (18 citations), Pharmacology (61 citations) and Periodontics (13 citations). Minoru Nagi has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Yoshitsugu Miyazaki, Koichi Tanabe, Keigo Ueno, Takashi Umeyama, Hironobu Nakayama, Satoshi Yamagoe, Hideaki Ohno, Toshihiro Aoyama, Masakazu Niimi and Masahiro Abe. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Medical Mycology, Molecular Microbiology, PLoS ONE and Genes to Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.